Dan Qin | Scientist III
Genentech | United States

Dan Qin is currently a Scientist III in the Department of Biochemical and Cellular Pharmacology. She is recognized as a leading expert in immunogenicity risk assessment for biotherapeutics, a critical field that ensures laboratory-designed medicines do not trigger harmful immune responses in patients.

At Festival of Biologics USA 2026, Dan will share his insights and experiences in navigating the complex journey of bringing biologics from discovery to market. Attendees can expect to gain valuable knowledge and practical strategies to accelerate the development of biologic therapies and overcome challenges in the drug development process. Don't miss the opportunity to learn from Dan Qin and discover how to unlock the full potential of biologics in healthcare.